Lansoprazole Capsule, Delayed Release
Product Images NDC 80425-0174

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 80425-0174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig 1 (Fig 1)

This text presents a chart showing the mean severity of day heartburn for evaluable patients by study day. The severity is represented by a scale of 0 (none) to 3 (severe). The chart compares the severity of heartburn for patients taking a placebo, lansoprazole 15 mg, and lansoprazole 30 mg. The data is presented for a period of 6 days from the start of treatment.*

FDA Label Image

Fig 2 (Fig 2)

The text describes a chart or graph displaying the mean severity of night heartburn for evaluable patients based on a study day, with severity levels ranging from severe to none. The chart includes data for three groups: a placebo group, a group taking lansoprazole 15 mg once daily, and a group taking lansoprazole 30 mg once daily. The x-axis displays the days from the start of treatment. The chart seems to have 6 data points with a maximum mean severity of 18 and a minimum of 16.*

FDA Label Image

Lansoprazole Dr 30mg Cap #30 (Lansoprazole Dr 30mg Cap Qty 30 Ndc 80425 0174)

FDA Label Image

Logo (Logo)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.